LOGIN  |  REGISTER
Terns Pharmaceuticals
Terns Pharmaceuticals

Addus HomeCare to Participate in Upcoming Investor Conferences in May

May 06, 2025 | Last Trade: US$112.38 2.11 1.91

FRISCO, Texas / May 06, 2025 / Business Wire / Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May:

  • BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025.
  • 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice President and Chief Financial Officer will present at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on Tuesday, May 20, 2025.

In connection with the virtual conferences, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 260 locations across 23 states. For more information, please visit www.addus.com.

Viking Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page